TREACE MEDICAL CONCEPTS INC. - COMMON STOCK
5.7500
28-July-25 13:45:00
15 minutes delayed
Stocks
+0.0500
+0.88%
Today's range
5.6400 - 5.8500
ISIN
N/A
Source
NASDAQ
-
04 Nov 2024 04:00:00 By Nasdaq GlobeNewswire
-
Treace to Report Third Quarter 2024 Financial Results on November 5, 2024
22 Oct 2024 13:30:00 By Nasdaq GlobeNewswire
-
14 Oct 2024 06:45:34 By Nasdaq GlobeNewswire
-
11 Sep 2024 05:00:00 By Nasdaq GlobeNewswire
-
Treace Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
22 Aug 2024 13:15:00 By Nasdaq GlobeNewswire
-
Treace Medical Concepts Reports Second Quarter 2024 Financial Results
06 Aug 2024 13:05:00 By Nasdaq GlobeNewswire
-
Treace to Report Second Quarter 2024 Financial Results on August 6, 2024
18 Jul 2024 13:30:00 By Nasdaq GlobeNewswire
-
Treace to Present at Truist Securities MedTech Conference
28 May 2024 04:00:00 By Nasdaq GlobeNewswire
-
Treace Medical Concepts Reports First Quarter 2024 Financial Results
07 May 2024 13:05:01 By Nasdaq GlobeNewswire
-
24 Apr 2024 04:00:00 By Nasdaq GlobeNewswire
-
Treace to Present at Bank of America Health Care Conference
17 Apr 2024 04:00:00 By Nasdaq GlobeNewswire
-
Treace Announces First Annual National Bunion Day
16 Apr 2024 04:00:00 By Nasdaq GlobeNewswire
-
Treace to Report First Quarter 2024 Financial Results
09 Apr 2024 04:00:00 By Nasdaq GlobeNewswire
-
Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone
25 Mar 2024 04:00:00 By Nasdaq GlobeNewswire
-
27 Feb 2024 13:05:00 By Nasdaq GlobeNewswire
-
Treace to Report Fourth Quarter and Full-Year 2023 Financial Results
07 Feb 2024 13:05:00 By Nasdaq GlobeNewswire
-
02 Feb 2024 09:00:00 By Nasdaq GlobeNewswire
-
01 Feb 2024 04:00:00 By Nasdaq GlobeNewswire
-
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue
08 Jan 2024 04:00:00 By Nasdaq GlobeNewswire
-
Treace to Present at 42nd Annual J.P. Morgan Healthcare Conference
19 Dec 2023 04:00:00 By Nasdaq GlobeNewswire